Singapore IPO Reality Check: Why New Listings Can Fall Below Their IPO Price

Singapore IPO Reality Check: Why New Listings Can Fall Below Their IPO Price

An IPO price is not a guarantee of what a stock is worth after listing.

Singapore’s IPO market has become much more active in 2026, but many new listings have struggled once public trading began.

By early September, seven of eight companies that had listed on the SGX in 2026 were trading below their offer prices.

That raises an important question:

Why can a heavily marketed IPO fall almost immediately after listing?

Educational research only. This article is not investment advice.

What Is an IPO Price?

An initial public offering, or IPO, is when a company sells shares to public investors for the first time.

Before listing, the company and its advisers determine an offer price.

That price is influenced by:

  • expected earnings;
  • comparable companies;
  • investor demand;
  • market conditions;
  • growth forecasts.

But it is still a negotiated starting price.

Once trading begins, the market takes over.

IPO price ≠ guaranteed fair value.

Singapore’s 2026 IPO Reality

Singapore’s IPO market has improved significantly after several quiet years.

Five listings raised around S$1.1 billion in the first half of 2026, compared with only one IPO during the same period in each of the previous two years.

But post-listing performance has been much weaker.

Among the five Mainboard IPOs reviewed by The Business Times in September, only EGP Energy Corp was trading above its IPO price. UI Boustead REIT, JustCo, Foundation Healthcare and All-Link Air & Sea were below theirs.

A stronger IPO market therefore does not automatically mean stronger IPO returns.

Why Can an IPO Fall Below Its Offer Price?

1. The IPO Was Priced Too Aggressively

Companies naturally want to raise as much money as possible.

But investors need enough potential upside to justify taking the risk of owning a newly listed company.

OCBC has argued that Singapore IPOs increasingly need either a compelling growth story or a meaningful valuation discount because existing SGX companies already offer strong alternatives.

If the IPO arrives at an expensive valuation, buyers may disappear after listing.

2. Initial Demand Can Be Misleading

An IPO can be heavily subscribed and still fall.

JustCo’s IPO was 3.4 times subscribed, yet the stock opened 11.2% below its S$0.94 offer price and finished its first trading day 17.6% lower at S$0.775.

This shows an important distinction:

Strong subscription demand does not guarantee strong secondary-market demand.

Once trading starts, investors reassess the valuation in real time.

3. Small Floats Can Increase Volatility

Many Singapore IPOs are relatively small.

If only a limited number of shares trade publicly, relatively modest buying or selling can move the price sharply.

Low liquidity can create:

  • wider bid-ask spreads;
  • larger price gaps;
  • stronger reactions to individual orders.

That makes some newly listed shares more volatile than established large-cap stocks.

4. Expectations Can Change Quickly

An IPO prospectus is based partly on expectations about the future.

After listing, investors receive new information:

  • earnings;
  • guidance;
  • industry data;
  • interest-rate changes;
  • economic news.

If the company’s outlook disappoints, the valuation can reset quickly.

The company does not need to become a bad business.

It may simply fail to deliver the growth already built into the IPO price.

5. Market Sentiment Matters

Even a strong company can list at a difficult time.

New stocks compete with every other investment available.

If investors prefer:

  • established blue chips;
  • Singapore banks;
  • high-yield S-REITs;
  • technology leaders;

they may demand a larger discount before taking the additional uncertainty of a new listing.

That can pressure IPO prices after the initial excitement fades.

IPO Price vs Fair Value

This is the central lesson.

Suppose a company lists at:

S$1.00

That does not mean S$1.00 is objectively its fair value.

If investors later decide the business deserves only S$0.80, the stock can fall 20%.

Alternatively, if growth exceeds expectations, the stock may rise far above the offer price.

The IPO price is therefore:

a starting valuation, not a price floor.

Why Lock-Ups Matter

Founders and early investors are often prevented from immediately selling all their shares after an IPO.

These restrictions are known as lock-up periods.

When a lock-up expires, more shares can potentially become available for sale.

That does not guarantee the stock will fall.

But investors should know when additional supply may enter the market.

How Risk Simulation Fits

TradingSimuLab’s Risk Simulation helps shift attention away from IPO hype and toward possible outcomes.

Important areas include:

Probability of Gain

How often do simulated paths finish above the starting point?

VaR

Where does severe downside begin?

CVaR

How damaging are losses beyond that threshold?

Max Drawdown

How far could the stock fall from a previous peak?

Terminal Price Range

How wide is the distribution of potential ending prices?

A new listing may offer strong growth potential.

But investors should also understand how uncertain the price path can be.

A Simple Singapore IPO Checklist

Before judging a new listing, ask:

Valuation
Is the IPO priced attractively relative to comparable companies?

Growth
How quickly are revenue and earnings expected to grow?

Use of proceeds
Is the company raising money for expansion—or mainly allowing existing shareholders to sell?

Liquidity
How many shares will actually trade publicly?

Profitability
Is the business already profitable?

Competition
Does the company have a defensible market position?

Risk-reward
Is enough upside being offered for the uncertainty?

These questions matter more than whether an IPO is heavily oversubscribed.

Final Takeaway

Singapore’s IPO market is recovering.

But the performance of 2026 listings shows why investors should separate:

IPO excitement

from:

investment value.

The useful framework is:

IPO Price → Valuation → Earnings → Liquidity → Market Demand → Post-Listing Return

A stock falling below its IPO price does not automatically mean the company is poor.

It may simply mean:

the market now values the company differently from the original offering.

So instead of asking:

“Will this IPO pop on the first day?”

Ask:

“Is the valuation attractive enough to justify the risk after the excitement disappears?”

For more Singapore market research, risk analysis and market simulations, sign up to TradingSimuLab and explore the platform.

Continue exploring TradingSimuLab.

  • Software Stocks: Can AI Turn From a Threat Into a Revenue Opportunity?

    If artificial intelligence could build applications, automate workflows and let companies create their own tools, why keep paying large subscription fees to traditional software providers? That fear hit companies such as Salesforce and ServiceNow hard. Now the story may be changing. Salesforce recently reported its strongest growth in net new annual order value in four…

  • AI Training Data: Is Data Becoming More Valuable Than the Model?

    The AI race is no longer only about building bigger models. Increasingly, it is also about building better data. That shift is visible in the rise of Snorkel AI, which recently raised $350 million at a $3.5 billion valuation as demand grows for specialized datasets, reinforcement-learning environments and expert-generated training material. Its annualized revenue has…

  • Why Shipping Costs Can Move Oil Prices Even When Supply Is Available

    Oil prices can rise even when plenty of crude exists. One reason is often overlooked: shipping costs. Recent Venezuelan crude trades show the problem clearly. Reuters reported that tanker costs from Venezuela’s Jose port to the U.S. Gulf had risen to roughly $3.5 million per Aframax voyage, forcing traders to demand deeper discounts on the…

  • Currency Intervention Explained: Can Governments Stop a Falling Currency?

    A currency can keep falling even after interest rates rise. That is exactly why currency intervention periodically returns to the spotlight. The Japanese yen recently traded around 157.5 per U.S. dollar despite the Bank of Japan raising its policy rate to 1.25%. Markets remain alert to another possible intervention after reports of Japanese authorities checking…

  • India Stock Market: Why Global Banks Are Rushing Back In

    Global banks are paying closer attention to India’s capital markets. HSBC is preparing to re-enter India’s equity-broking business after more than a decade away, rebuilding its equities platform as IPO activity and demand from wealthy investors expand. Reuters reports that the bank is hiring for cash-equities and institutional-broking roles and may also relaunch retail broking…

  • Solar Stocks India: Can Domestic Panel Makers Compete With China?

    India is building a much larger domestic solar manufacturing industry. One of the clearest signs is Avaada Electro, which is preparing a major IPO as it expands solar-cell and module production. The company currently has about 8.5 GW of module capacity and is targeting 13.6 GW, alongside major expansion in solar-cell manufacturing. For investors watching…

  • Japan Bond Yields: Why Higher Rates Can Move Global Markets

    For decades, Japanese investors sent enormous amounts of money overseas in search of higher returns. That may be starting to change. Japan bond yields recently pushed above 3% on the 10-year government bond, the highest level since 1996. At the same time, Japanese investors have begun reducing some overseas bond exposure as domestic bonds become…

  • Corporate Governance Explained: Why Shareholder Rights Matter as Much as Earnings

    Investors spend enormous amounts of time studying revenue, margins and earnings. But sometimes the biggest risk sits somewhere else: Who actually controls the company? A recent dispute inside India’s Tata Group has brought corporate governance back into focus. Tata Sons and its controlling shareholder, Tata Trusts, have clashed over board authority, the reappointment of chairman…

  • Pharmaceutical Stocks: Why Europe Is Losing Ground in Drug Research

    Europe has some of the world’s largest pharmaceutical companies. But an increasing share of global drug research is happening elsewhere. European drugmakers say the region’s share of global pharmaceutical R&D has fallen from about 43% to 31%, while its share of commercial clinical trials has dropped to roughly 9% over the past decade. Industry leaders…